02.06.2012
- AstraZeneca and Bristol-Myers Squibb are among several pharmaceutical giants that have submitted initial bids for Amylin Pharmaceuticals, the diabetes drugmaker that is exploring a...
31.05.2012
- We are delighted to present you with this supplement for the ACHEMA 2012. On the next eight pages, we invite you to discover a one-of-a-kind reference, our leading resource, the...
31.05.2012
- When Dr. John Gerald FitzGerald developed a diphtheria antitoxin, he did it in Ontario. That was in 1914 and, since then, Ontario has achieved a number of medical research "firsts...
31.05.2012
- Industrial Biotech - The growing shortage and rising price of fossil energy has increased interest in finding economically attractive replacements that draw on biotechnology...
30.05.2012
- Billionaire investor Carl Icahn, who last year failed to get his nominees elected to the board of Forest Laboratories, plans to back another slate of directors at the drugmaker's...
30.05.2012
- GlaxoSmithKline plans to launch a campaign to replace the entire board of Human Genome Sciences with its own nominees, stepping up its $2.6 billion hostile bid for the U.S. biotech...
25.05.2012
- Knock-out data for Actelion's big new drug hope could be a double-edged sword for embattled founder and CEO Jean-Paul Clozel, making it a worthy buy for pharma companies hungry for...
24.05.2012
- Pharmaceutical companies, which were spared some of the more sweeping regulations in President Barack Obama's healthcare overhaul, could come under more pressure if the U.S...
24.05.2012
- Thermo Fisher Scientific, a maker of laboratory equipment, said it will focus on expanding sales in emerging markets to help drive annual revenue growth in the mid-single-digit...
22.05.2012
- DSM is going to invest approximately €100 million in three new R&D facilities in Delft and Sittard-Geleen (both in the Netherlands) over the next two years. The investment in Delft...
